Inhibitory effect of dates-extract on α -Amylase and α-glucosidase enzymes relevant to non-insulin dependent diabetes mellitus Sulaiman Al-Zuhair*, Ali Dowa idar and Hassan Kamal
Received: 4 April 2010 / Received in revised form: 9 June 2010, Accepted: 9 June 2010, Published online: 7 July 2010
Abstract
α-Amylase and α-glucosidase are key enzymes involved in
available anti-diabetic drugs used to treat non-insulin dependent
carbohydrates breakdown and intestinal absorption, respectively.
diabetes mellitus NIDDM, such as Acarbose, strongly inhibits both
Inhibition of these enzymes hinders blood glucose level increase
enzymes. However, patients using Acarbose usually suffer from
after a carbohydrate diet and can be an important strategy in the
abdominal distention, flatulence, meteorism and possibly diarrhea
management of non-insulin-dependent diabetes mellitus (NIDDM).
(Bischoff, 1994). These side effects are caused by the excessive
A main drawback of currently used inhibitors is their side effects
inhibition of pancreatic α-amylase resulting in the abnormal
such as abdominal distention, flatulence, meteorism and diarrhea,
bacterial fermentation of undigested carbohydrates in the colon
caused by excessive inhibition of pancreatic α-amylase resulting in
(Bischoff, 1994; Horii, 1987). Therefore it is attractive to find a
abnormal bacterial fermentation of undigested carbohydrates in the
substance that has a strong inhibitory activity against α-glucosidase,
colon. Natural inhibitors from plants have shown lower inhibitory
but minor effect on α-amylase activity (Kwon et al., 2006). As dates
effect against α-amylase activity and a stronger inhibitory activity
represent large portion of sugar source in Middle Eastern diet, it
against α-glucosidase and can be used as effective therapy for
would be advantages to find out if they have positive effect on
NIDDM with minimal side effects. In this work dates-extract (DE)
NIDDM. The results of this work will open the door for further
inhibitory effect on α-amylase and α-glucosidase has been assessed.
investigation into the active agents that cause the inhibitory effect,
The inhibition percentages on α-amylase and α-glucosidase were in
which can be extracted and used as a natural drug.
the range of 6-24% and 54%, respectively. The results clearly show the NIDDM treatment potential of DE.
Chemicals and Methods Keywords: Diabetes, dates-extract, α-amylase, α-glucosidase, Chemicals
Dates-syrup was purchased from local market and dates-pits
Introduction
granules were obtained from Al-Saad Dates Processing Factory, UAE. α-Amylase from
Aspergillus oryzae, 1.5 units mg-1 and α-
-Amylase and α-glucosidase are enzymes involved in starch
glucosidase from Saccharomyces cerevisiae Type I, lyophilized
breakdown and intestinal absorption, respectively. The first enzyme
powder with ≥10 units mg-1 were purchased from Sigma-Aldrich,
is involved in the digestion of carbohydrates to produce simpler
USA. All other chemicals were of analytical grade and purchased
saccharides, whereas the second is involved in their absorption. It is
believed that inhibition of the two enzymes would result in a lower blood glucose levels after a rich carbohydrate diet. The current
Dates- and dates-pits extracts preparation
Dates-extract (DE) was prepared by mixing 50 ml of dates-syrup
Sulaiman Al-Zuhair*, Ali Dowaidar and Hassan Kamal
thoroughly with to 50 ml of distilled water. The mixture was then
centrifuged at 4000 rpm (ICE CL31 Multispeed Centrifuge,
Department of Chemical and Petroleum Engineering, UAE
Thermoscientific, USA), and the supernatant was vacuum-filtered
University, Al-Ain, United Arab Emirates
(Shel Lab, USA). Vacuum was generated using jet pump and the
filter paper used was Whatman-Gade 1(11 μm).
*Tel: +9713713363; Fax: +97137624262 Email: s.alzuhair@uaeu.ac.ae
Dates-pits extract (DPE) was prepared by initially washing the
granules. Then they were dried and course grinded using Sanyo,
Japan grinder and then fine grinded using Moulinex, France grinder.
The particles were then screened in Pascal Eng. Co. Ltd., England
using mesh 70-120, which gives particle sizes in the range of 125-
212 μmand screened. 20 g of the collected granules were dispersed
in 50 ml distilled water in a screw capped bottle. The bottle was
increased at higher substrate concentration reaching 24% at initial
kept on a shaker (WSB-30, Korea) at 350 rpm for 24 hours to reach
equilibrium. The mixture was then vacuum-filtered (Shel Lab, USA).
-Amylase assay
The reactions took place in ten test tubes, each containing 1 ml
distilled water (or DE solution), 1 ml of 100 g l-1 starch solution in 2
mM phosphate buffer solution (pH 6.9) and 1 ml of 0.05 g l-1 α-
amylase in phosphate buffer solution. The test tubes were incubated
at 37 oC (which represent normal body temperature). The enzymatic
reaction was stopped by adding 50 μl of 1 M HCl to each test tube at
different times in the range of 10 to 100 seconds, with 10 minutes
intervals between the test tubes. The reducing sugar formed in the
reaction was measured by 3,5-dinitrosalicylic acid (DNS) method
using maltose as the standard (Miller, 1959) and was used to
determine the activity of α-amylase. One unit of α-amylase was
defined as the amount of enzyme required to produce 1 µmol of
reducing equivalents per minute from soluble starch under the assay
conditions. The experiment was then repeated at different initial
amounts of substrate in the range of 33 g l-1 to 66 g l-1.
α-Glucosidase assay Time, t (min)
A modified method to the one used by (Kwon et al., 2008) has been
Figure 1: Effect of DE on enzymatic production of deviation maltose at
starch concentration of 33 g l-1 (o without DE and with DE)
with time. α-Glucosidase activity was assayed using 1 ml of 0.35 mM p-nitrophenyl-α-D-glucopyranoside solution in 100 μmol of
α-Glucosidase inhibition
acetate buffer (pH 4.5) mixed with 1 ml of distilled water (or DE or DPE solutions), 0.5 ml of 200 mM Na
The rate of p-phenol production was determined using different
α-glucosidase solution. The reaction took place in a special vial
initial p-nitrophenyl-α-D-glucopyranoside solution, with the
placed in the spectrophotometer, and the absorbance at 405 nm was
presence of DE and DPE and in absence of any inhibition. For
recorded as a function of time. The absorbance was compared to
reference, the experiment was also repeated in absence of α-
that of standard solutions of p-nitrophenol and the results were used
glucosidase. The results at initial substrate concentration of 0.35
to determine the activity of α- glucosidase. One unit of α-
mM are shown in Fig. 2. All experiments were done in duplicate,
glucosidase was defined as the amount of enzyme required to
and the reproducibility of the results is confirmed from the small
error bars shown in the figure. The results show that the presence of
p-nitrophenol per minute under the assay
conditions. The experiment was then repeated at different initial
DE has significant effect on the activity of α-glucosidase. On the
amounts of substrate in the range of 0.07 mM to 0.42 mM. The
other hand, only slight inhibition effect was observed in the
experiment was also run at substrate concentration of 0.35 mM in
presence of DPE. Table 2 shows α-glucosidase inhibition of DE and
absence of α-glucosidase as a reference.
DPE. It can be seen that the presence of DE significantly inhibited α-glucosidase, and reduced its activity by 54%, which is almost
Results and Discussion
equal to the absence of enzyme. This indicated that the DE almost completely inhibited the enzyme. On the other hand, date-pits
α-Amylase inhibition
extract, inhibited the enzyme much less and percentage reduction of
The rate of reduced sugar production was determined using different
only 30% was observed. Similar results were observed at other
initial starch concentrations, with and without the presence of DE.
initial starch concentration in the range of 0.07 - 0.42 mM, and the
To eliminate the effect of reduced sugar initially found in the date-
extract, the results were presented in terms of deviation maltose
Table 1: Substrate concentration effect on α-amylase activity
concentration, P, defined as difference between the concentration of
reduced sugar at anytime and that at time zero. An example of the
-amylase activity(U) percentage [S] (g l-1)
deviation maltose production with time, with and in absence of DE,
reduction Without DE
at initial starch concentration of 33 g l-1 is shown in Fig. 1. All experiments were done in duplicate, and the reproducibility of the
results is confirmed from the small error bars shown in the figure.
Although slight inhibition effect was observed, the results show that
the presence of DE has insignificant effect on the activity of α-amylase. Similar results were also observed at other initial starch
The use of DE in the treatment of NIDDM
concentration in the range of 33 to 66 g l-1.
Results indicated that DPE slightly inhibits the activity of α-
α-Amylase activity was determined at different initial substrate
amylase. The inhibition percentage was in the range of 6-24%,
concentrations and the results are shown in Table 1, with and
depending on the initial substrate concentration. The inhibition
without the presence of DE. It can be seen that the presence of DE
effect of DE was less than that of egg-plant extract used by Kwon et
slightly inhibited α-amylase with less than 10% inhibition at
al. (2008), which was in the range of 14-38%. This is a favourable
concentrations 33 and 50 g l-1. However, the inhibition effect
Conclusion The inhibition effect of DE on the activity of α-amylase and α-
glucosidase has been experimentally assessed. The results show that
DE inhibits α-glucosidase more than it does on α-amylase, which is
a positive result. The findings of this work clearly show the DE
Acknowledgment
The authors would like to acknowledge the financial support
provided by the Research Affairs at the UAE University.
p References
Bischoff H (1994) Pharmacology of glucosidase inhibitor. Eur J
Time, t (min)
Horii S (1987) Synthesis and α-D-glucosidase inhibitory activity of
Nsubstituted valiolamine derivatives as potent oral antidiabetic
Figure 2: DE and DPE effect on p-phenol production, at initial substrate
concentration of 0.35 mM (o without enzyme, with DE, with DPE and
Kwon YI, Apostolidis E, Shetty K (2008) In vitro studies of
eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Biores
result, since as explained earlier, the excessive inhibition of α-
amylase results in abnormal bacterial fermentation of undigested
Kwon YI, Vattem DV, Shetty K (2006) Evaluation of clonal herbs
carbohydrates in the colon, which intern results in abdominal
of Lamiaceae species for management of diabetes and
distention, flatulence, meteorism and possibly diarrhea (Bischoff,
hypertension. Asia Pac J Clin Nutr 15:107–118
1994). On the other hand, it was found that DPE strongly inhibits
Miller GL (1959) Use of dinitrosalicylic acid reagent for
determination of reducing sugar. Anal Chem 31:426–428
Rosetti LL, Giacarri A, Defronzo RA (1990) Glucose toxicity.
Shetty K, Curtis OF, Levin RE, Wikowsky R, Ang W (1995)
Prevention of verification associated with in vitro shoot culture
of oregano (Origanum vulgare) by Pseudomonas spp. J Plant
Initial Substrate Concentration, [S]o (mM) Figure 3: Substrate concentration effect on α-glucosidase activity ( without inhibitors, with DPE, with DE)
the activity of α- glucosidase and renders it almost inactive. The inhibition percentage using DE is found to be 54%, which is higher than the egg plant extract inhibition which was in the range of 5-46% (Kwon et al., 2008).
Table 2: Effect of inhibitors on α-glucosidase activity Percentage
α-glucosidase activity(U) reduction
El Carvedilol reduce la morbilidad y la mortalidad en pacientes con insuficiencia cardíaca severa. Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P et al for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 2001; 344: 1651-1658. Objetivo: Valorar el efecto sobre la mortalid
FRAGEBOGEN ZUM GESUNDHEITSZUSTAND (Seite 1)Name:___________________________________________________________________Beruf:___________________________________________________________________Familienstand:___________________________________________________________________Wurden Sie in letzter Zeit ärztlich behandelt,_______________________________________________________________________________